Xu D - Search Results

1

Discovery of novel, potent and low-toxicity angiotensin II receptor type 1 (AT1) blockers: Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazoles with a chiral center.

Han XF, He X, Wang M, Xu D, Hao LP, Liang AH, Zhang J, Zhou ZM. Han XF, et al. Among authors: xu d. Eur J Med Chem. 2015 Oct 20;103:473-87. doi: 10.1016/j.ejmech.2015.09.010. Epub 2015 Sep 12. Eur J Med Chem. 2015. PMID: 26397395

2

Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.

Wang JL, Zhang J, Zhou ZM, Li ZH, Xue WZ, Xu D, Hao LP, Han XF, Fei F, Liu T, Liang AH. Wang JL, et al. Among authors: xu d. Eur J Med Chem. 2012 Mar;49:183-90. doi: 10.1016/j.ejmech.2012.01.009. Epub 2012 Jan 17. Eur J Med Chem. 2012. PMID: 22309912

3

Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.

Zhang J, Wang JL, Zhou ZM, Li ZH, Xue WZ, Xu D, Hao LP, Han XF, Fei F, Liu T, Liang AH. Zhang J, et al. Among authors: xu d. Bioorg Med Chem. 2012 Jul 15;20(14):4208-16. doi: 10.1016/j.bmc.2012.05.056. Epub 2012 Jun 5. Bioorg Med Chem. 2012. PMID: 22727371

4

Nonpeptidic angiotensin II AT₁ receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.

Zhang J, Wang JL, Yu WF, Zhou ZM, Tao WC, Wang YC, Xue WZ, Xu D, Hao LP, Han XF, Fei F, Liu T, Liang AH. Zhang J, et al. Among authors: xu d. Eur J Med Chem. 2013 Nov;69:44-54. doi: 10.1016/j.ejmech.2013.08.014. Epub 2013 Aug 19. Eur J Med Chem. 2013. PMID: 24007859

5

Asymmetric hydrogenation of aromatic ketones by new recyclable ionic tagged ferrocene-ruthenium catalyst system.

Xu D, Zhou ZM, Dai L, Tang LW, Zhang J. Xu D, et al. Bioorg Med Chem Lett. 2015 May 1;25(9):1961-4. doi: 10.1016/j.bmcl.2015.03.023. Epub 2015 Mar 14. Bioorg Med Chem Lett. 2015. PMID: 25819097

6

Enantiomeric separation in high-performance liquid chromatography using novel β-cyclodextrin derivatives modified by R-configuration groups as chiral stationary phases.

Li X, Zhou ZM, Xu D, Zhang J. Li X, et al. Among authors: xu d. Talanta. 2011 May 30;84(4):1080-92. doi: 10.1016/j.talanta.2011.03.023. Epub 2011 Mar 16. Talanta. 2011. PMID: 21530782

7

A novel enantioselective synthesis of 6H-dibenzopyran derivatives by combined palladium/norbornene and cinchona alkaloid catalysis.

Xu D, Dai L, Catellani M, Motti E, Della Ca' N, Zhou Z. Xu D, et al. Org Biomol Chem. 2015 Feb 28;13(8):2260-3. doi: 10.1039/c4ob02551b. Org Biomol Chem. 2015. PMID: 25584921

8

Correction: A novel enantioselective synthesis of 6H-dibenzopyran derivatives by combined palladium/norbornene and cinchona alkaloid catalysis.

Xu D, Dai L, Catellani M, Motti E, Della Ca' N, Zhou Z. Xu D, et al. Org Biomol Chem. 2015 Feb 28;13(8):2481. doi: 10.1039/c5ob90021b. Org Biomol Chem. 2015. PMID: 25629771

9

A sequential Pd/norbornene-catalyzed process generates o-biaryl carbaldehydes or ketones via a redox reaction or 6H-dibenzopyrans by C-O ring closure.

Motti E, Della Ca' N, Xu D, Piersimoni A, Bedogni E, Zhou ZM, Catellani M. Motti E, et al. Among authors: xu d. Org Lett. 2012 Nov 16;14(22):5792-5. doi: 10.1021/ol302889t. Epub 2012 Nov 7. Org Lett. 2012. PMID: 23134173

10

Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten.

Xu D, Lutz JD, Divanji P, Li J, Benattia Y, Griffith A, Heitner SB, Kupfer S, German P. Xu D, et al. Clin Pharmacokinet. 2025 Feb 5. doi: 10.1007/s40262-025-01481-9. Online ahead of print. Clin Pharmacokinet. 2025. PMID: 39907965

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,092 results

Search Page

Filters